Literature DB >> 27107055

Bilateral cloudy cornea: is the usual suspect congenital hereditary endothelial dystrophy or stromal dystrophy?

Banu Torun Acar1, Kansu Tahir Bozkurt2, Erkan Duman3, Suphi Acar4.   

Abstract

We provide the diagnosis, treatment and follow-up period of a patient with cloudy cornea in both eyes from birth. A 4-year-old girl presented with blurring in both eyes. Penetrating keratoplasty (PK) was performed with the preliminary diagnosis of congenital hereditary endothelial dystrophy in June 2012. According to the pathology report for extracted host tissue, the Descemet's membrane (DM) and endothelium were healthy and diagnosis was reported to be congenital hereditary stromal dystrophy. Deep anterior lamellar keratoplasty was performed on the left eye. The DM was transparent at follow-up. Cornea transplantation is the only choice to provide visual rehabilitation in children with congenital cloudy cornea. However, it is known that the prognosis of traditional PK in the paediatric age group is not good. Therefore, when using alternative keratoplasty (deep anterior lamellar keratoplasty, Descemet's stripping automated endothelial keratoplasty) options, pathological examination of the host tissue should be made. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27107055      PMCID: PMC4854138          DOI: 10.1136/bcr-2015-214094

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  Corneoscleral transplantation in congenital corneal staphyloma and Peters' anomaly.

Authors:  Marijean M Miller; Selim Butrus; Ahmed Hidayat; Lisa L Wei; Manuel Pontigo
Journal:  Ophthalmic Genet       Date:  2003-03       Impact factor: 1.803

2.  Further studies of congenital hereditary endothelial dystrophy of the cornea.

Authors:  K R Kenyon; A E Maumenee
Journal:  Am J Ophthalmol       Date:  1973-10       Impact factor: 5.258

3.  Clinical differentiation of recessive congenital hereditary endothelial dystrophy and dominant hereditary endothelial dystrophy.

Authors:  G F Judisch; I H Maumenee
Journal:  Am J Ophthalmol       Date:  1978-05       Impact factor: 5.258

Review 4.  Deep anterior lamellar keratoplasty as an alternative to penetrating keratoplasty a report by the american academy of ophthalmology.

Authors:  William J Reinhart; David C Musch; Deborah S Jacobs; W Barry Lee; Stephen C Kaufman; Roni M Shtein
Journal:  Ophthalmology       Date:  2011-01       Impact factor: 12.079

5.  Endothelial cell loss and visual outcome of deep anterior lamellar keratoplasty versus penetrating keratoplasty: a randomized multicenter clinical trial.

Authors:  Yanny Y Y Cheng; Nienke Visser; Jan S Schouten; Robert-Jan Wijdh; Elisabeth Pels; Hugo van Cleynenbreugel; Catharina A Eggink; Michel J W Zaal; Wilhelmina J Rijneveld; Rudy M M A Nuijts
Journal:  Ophthalmology       Date:  2010-09-15       Impact factor: 12.079

6.  Deep anterior lamellar keratoplasty for keratoconus.

Authors:  Abdullah A Al-Torbak; Saeed Al-Motowa; Abdullah Al-Assiri; Soliman Al-Kharashi; Sami Al-Shahwan; Hani Al-Mezaine; Klaus Teichmann
Journal:  Cornea       Date:  2006-05       Impact factor: 2.651

7.  A novel mutation of the decorin gene identified in a Korean family with congenital hereditary stromal dystrophy.

Authors:  Jae-hyung Kim; Jung Min Ko; Inchul Lee; Jae Yong Kim; Myoung Joon Kim; Hungwon Tchah
Journal:  Cornea       Date:  2011-12       Impact factor: 2.651

8.  Congenital corneal opacities in a cornea referral practice.

Authors:  Renata A Rezende; Uchoandro B C Uchoa; Raquel Uchoa; Christopher J Rapuano; Peter R Laibson; Elisabeth J Cohen
Journal:  Cornea       Date:  2004-08       Impact factor: 2.651

9.  Congenital hereditary stromal dystrophy of the cornea.

Authors:  H Witschel; B S Fine; P Grützner; J W McTigue
Journal:  Arch Ophthalmol       Date:  1978-06

10.  Outcome of surgery on infants younger than 1 month with congenital glaucoma.

Authors:  Anil K Mandal; Vijaya K Gothwal; Harmohina Bagga; Rishita Nutheti; Tarannum Mansoori
Journal:  Ophthalmology       Date:  2003-10       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.